Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» generics
generics
BioDelivery Sciences, Teva settle patent fight over opioid dependence treatment
Drug Delivery Business News
Thu, 10/12/17 - 10:11 am
BioDelivery Sciences
Teva Pharmaceutical
opioid addiction
opioids
Bunavail
generics
Teva scrambles to match 30% Copaxone discounts from Mylan's knockoff: analyst
Fierce Pharma
Mon, 10/9/17 - 07:43 pm
Teva Pharmaceutical
Mylan Labs
Copaxone
drug discounts
generics
FDA’s Getting a Complex
FDA Law Blog
Mon, 10/9/17 - 09:37 am
FDA
generics
complex drugs
3 Drug Stocks That Soared This Week
Motley Fool
Sun, 10/8/17 - 11:26 am
Endocyte
PSMA-617
MannKind
Afrezza
Mylan Labs
generics
Teva Pharmaceutical
Lilly wards off another Alimta patent challenge, this time through IPR
Fierce Pharma
Fri, 10/6/17 - 11:42 am
Eli Lilly
Alimta
patents
IPR
lung cancer
Neptune
generics
Novartis
Sandoz
FDA’s Gottlieb pushes new generics rules to encourage price competition
Fierce Pharma
Wed, 10/4/17 - 11:07 am
FDA
Scott Gottlieb
generics
competition
[video+transcript]The Creative Ways Drugmakers Are Delaying Generics
Motley Fool
Tue, 09/26/17 - 11:19 am
generics
AbbVie's Unfazed by the Risk of Generic Humira
Motley Fool
Mon, 09/25/17 - 09:45 am
AbbVie
generics
Humira
Generics Industry Calls FDA Draft Guidance on Priority Reviews 'Basically Inoperable'
RAPS.org
Sun, 09/24/17 - 10:25 am
generics
FDA
priority review
With U.S. Generic Drug Market in Chaos, Indian Upstarts Rise
Bloomberg
Thu, 08/31/17 - 12:06 pm
generics
India
Allergan heads to federal court to defend Restasis against early generic rivals
Fierce Pharma
Tue, 08/29/17 - 09:14 pm
Allergan
Restasis
generics
Mylan Labs
Teva Pharmaceutical
Akorn
InnoPharma
5 Important Healthcare Predictions For 2018
Forbes
Tue, 08/22/17 - 09:59 am
specialty diseases
M&A
generics
technology
Asia
Mylan Can Focus on New Generics After EpiPen Medicaid Settlement
TheStreet.com
Tue, 08/22/17 - 12:08 am
Mylan Labs
generics
EpiPens
Medicaid
Sun's profit crushed as it pays $150M to settle Provigil pay-for-delay case
Fierce Pharma
Sun, 08/13/17 - 10:40 am
Sun Pharma
Provigil
pay-for-delay
generics
Mylan Labs
Teva kept quiet for weeks on forthcoming generics blow: report
Fierce Pharma
Sat, 08/12/17 - 11:56 am
Teva Pharmaceutical
generics
Mylan points finger at FDA for failure to win nods on Advair, Copaxone copies
Fierce Pharma
Fri, 08/11/17 - 10:55 am
Mylan Labs
FDA
Advair
Copaxone
generics
Teva Pharmaceutical
GSK
Spurred by Gottlieb, FDA on track to the most generic drug OKs ever in 1 year
Endpoints
Wed, 08/9/17 - 03:14 pm
FDA
generics
Scott Gottlieb
Mylan, like other generic drugmakers, feels the pricing pain
Stat
Wed, 08/9/17 - 03:10 pm
Mylan Labs
generics
drug pricing
FDA's generic competition push hits Valeant's Isuprel, a price-hike poster child
Fierce Pharma
Tue, 08/8/17 - 10:03 am
FDA
generics
Valeant Pharmaceuticals
Isuprel
drug pricing
nexus
Gottlieb: FDA to Issue new Policies to Streamline Generic Reviews in 2017
RAPS.org
Tue, 07/18/17 - 10:57 pm
FDA
generics
Scott Gottlieb
Pages
« first
‹ previous
…
24
25
26
27
28
29
30
31
32
…
next ›
last »